Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy

Clinical Science

Volumn 119, Issue 11, 2010, Pages 477-482

  Pereira, Marilia G A G ^a   Becari, Christiane ^a   Oliveira, José A C ^a   Salgado, Maria Cristina O ^a   Garcia Cairasco, Norberto ^a   Costa Neto, Claudio M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II type 1 receptor (AT 1 receptor); Angiotensin Converting Enzyme (ACE); Central nervous system; Epilepsy; Neurological disorder; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPILEPSY; FEMALE; HUMAN; MENTAL PATIENT; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEIZURE; UPREGULATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTICONVULSANTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENALAPRIL; EPILEPSY; FEMALE; HIPPOCAMPUS; LOSARTAN; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 78649824649     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100053     Document Type: Article

References (31)

1. Oliveira, L., Costa-Neto, C. M., Nakaie, C. R., Schreier, S., Shimuta, S. I. and Paiva, A. C. (2007) The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure. Physiol. Rev. 87, 565-592
2. Paul, M., Poyan Mehr, A. and Kreutz, R. (2006) Physiology of local renin-angiotensin systems. Physiol. Rev. 86, 747-803
3. von Bohlen und Halbach, O. and Albrecht, D. (2006) The CNS renin-angiotensin system. Cell Tissue Res. 326, 599-616
4. Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C. et al. (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117-121
5. Engel, J. (1995) Concepts of epilepsy. Epilepsia 36, S23-S29
6. Elger, C. E. and Schmidt, D. (2008) Modern management of epilepsy: a practical approach. Epilepsy Behav. 12, 501-539
7. Doretto, M. C., Fonseca, C. G., Lobo, R. B., Terra, V. C., Oliveira, J. A. and Garcia-Cairasco, N. (2003) Quantitative study of the response to genetic selection of the Wistar audiogenic rat strain WAR. Behav. Genet. 33, 33-42
8. Marescaux, C., Vergnes, M., Kiesmann, M., Depaulis, A., Micheletti, G. and Warter, J. M. (1987) Kindling of audiogenic seizures in Wistar rats: an EEG study. Exp. Neurol. 97, 160-168
9. Naritoku, D. K., Mecozzi, L. B., Aiello, M. T. and Faingold, C. L. (1992) Repetition of audiogenic seizures in genetically epilepsy-prone rats induces cortical epileptiform activity and additional seizure behaviors. Exp. Neurol. 115, 317-324
10. Dutra Moraes, M. F., Galvis-Alonso, O. U. and Garcia-Cairasco, N. (2000) Audiogenic kindling in the Wistar rat: a potential model for recruitment of limbic structures. Epilepsy Res. 39, 251-259
11. Romcy-Pereira, R. N. and Garcia-Cairasco, N. (2003) Hippocampal cell proliferation and epileptogenesis after audiogenic kindling are not accompanied by mossy fiber sprouting or Fluoro-Jade staining. Neuroscience 119, 533-546
12. Siebzehnrubl, F. A. and Blumcke, I. (2008) Neurogenesis in the human hippocampus and its relevance to temporal lobe epilepsies. Epilepsia (Suppl. 5) 49, 55-65
13. Argañaraz, G. A., Konno, A. C., Perosa, S. R., Santiago, J. F., Boim, M. A., Vidotti, D. B., Varella, P. P., Costa, L. G., Canzian, M., Porcionatto, M. A. et al. (2008) The renin-angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis. Epilepsia 49, 1348-1357
14. Yang, H. Y. and Neff, N. H. (1972) Distribution and properties of angiotensin converting enzyme of rat brain. J. Neurochem. 19, 2443-2450
15. Leite, R. and Salgado, M. C. (1992) Increased vascular formation of angiotensin II in one-kidney, one clip hypertension. Hypertension 19, 575-581
16. Garcia-Cairasco, N., Wakamatsu, H., Oliveira, J. A., Gomes, E. L., Del Bel, E. A. and Mello, L. E. (1996) Neuroethological and morphological Neo-Timm staining correlates of limbic recruitment during the development of audiogenic kindling in seizure susceptible Wistar rats. Epilepsy Res. 26, 177-192
17. Racine, R. J. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294
18. Ross, K. C. and Coleman, J. R. (2000) Developmental and genetic audiogenic seizure models: behavior and biological substrates. Neurosci. Biobehav. Rev. 24, 639-653
19. Haas, H. L., Felix, D., Celio, M. R. and Inagami, T. (1980) Angiotensin II in the hippocampus. A histochemical and electrophysiological study. Experientia 36, 1394-1395
20. Oz, M., Yang, K. H., O'Donovan, M. J. and Renaud, L. P. (2005) Presynaptic angiotensin II AT1 receptors enhance inhibitory and excitatory synaptic neurotransmission to motoneurons and other ventral horn neurons in neonatal rat spinal cord. J. Neurophysiol. 94, 1405-1412
21. Ozaki, Y., Soya, A., Nakamura, J., Matsumoto, T. and Ueta, Y. (2004) Potentiation by angiotensin II of spontaneous excitatory postsynaptic currents in rat supraoptic magnocellular neurones. J. Neuroendocrinol. 16, 871-879 (Pubitemid 40057596)
22. Wang, J. M., Tan, J. and Leenen, F. H. (2003) Central nervous system blockade by peripheral administration of AT1 receptor blockers. J. Cardiovasc. Pharmacol. 41, 593-599
23. Fournie-Zaluski, M. C., Fassot, C., Valentin, B., Djordjijevic, D., Reaux-Le Goazigo, A., Corvol, P., Roques, B. P. and Llorens-Cortes, C. (2004) Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc. Natl. Acad. Sci. U.S.A. 101, 7775-7780
24. Bodineau, L., Frugière, A., Marc, Y., Inguimbert, N., Fassot, C., Balavoine, F., Roques, B. and Llorens-Cortes, C. (2008) Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Hypertension 51, 1318-1325
25. Wells, T., Rippley, R., Hogg, R., Sakarcan, A., Blowey, D., Walson, P., Vogt, B., Delucchi, A., Lo, M. W., Hand, E., Panebianco, D. et al. (2001) The pharmacokinetics of enalapril in children and infants with hypertension. J. Clin. Pharmacol. 41, 1064-1074
26. MacFadyen, R. J., Meredith, P. A. and Elliott, H. L. (1993) Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. An overview. Clin. Pharmacokinet. 25, 274-282
27. Sica, D. A., Gehr, T. W. and Ghosh, S. (2005) Clinical pharmacokinetics of losartan. Clin. Pharmacokinet. 44, 797-814
28. Stragier, B., De Bundel, D., Sarre, S., Smolders, I., Vauquelin, G., Dupont, A., Michotte, Y. and Vanderheyden, P. (2008) Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review. Heart Failure Rev. 13, 321-337
29. Stragier, B., Clinckers, R., Meurs, A., De Bundel, D., Sarre, S., Ebinger, G., Smolders, I. and Michotte, Y. (2006) Involvement of the somatostatin-2 receptor in the anticonvulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats. J. Neurochem. 98, 1100-1113 (Pubitemid 44127786)
30. Garcia-Cairasco, N. (2006) Behavior, neural circuits and plasticity in acute and chronic models of generalized tonic-clonic seizures. In Progress in Epileptic Disorders, Generalized Seizures: from Clinical Phenomenology to Underlying Systems and Networks (Hirsch, E., Andermann, F., Chauvel, P., Engel, G., Silva, F. L. and Luders, H., eds.), pp. 197-228, John Libbey Eurotext, Mountrouge
31. Meldrum, B. (2002) Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs? Epilepsy Res. 50, 33-40